https://www.selleckchem.com/products/ifsp1.html
[This corrects the article DOI 10.1371/journal.pone.0249249.]. Hydroxychloroquine is widely used to treat certain viral and rheumatic diseases including systemic lupus erythematosus. Cardiac arrhythmia is an important safety issue with hydroxychloroquine. The aim of this study was to investigate whether hydroxychloroquine increases new-onset arrhythmia among patients with systemic lupus erythematosus. This was a nested case-control study using data from the Longitudinal Health Insurance Database of Taiwan. A conditional logistic regressio
Like
Comment
Share
